MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, MXCT had -$2,252K decrease in cash & cash equivalents over the period. -$7,758K in free cash flow.

Cash Flow Overview

Change in Cash
-$2,252K
Free Cash flow
-$7,758K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-12,416 -22,618
Depreciation and amortization
1,072 2,196
Lease right-of-use asset amortization
209 378
Net book value of consigned equipment sold
15 55
Loss on disposal of property and equipment
-19 -113
Stock-based compensation
1,954 6,553
Credit loss expense (recovery)
19 10
Change in excess/obsolete inventory reserve
360 165
Amortization of discounts on investments
584 1,635
Accounts receivable
2,572 1,077
Inventory
107 -754
Prepaid expense and other current assets
29 -773
Other assets
-216 1,140
Accounts payable, accrued expenses and other
2,002 -5,340
Operating lease liability
-346 -593
Deferred revenue
2,751 -2,831
Other liabilities
-21 -26
Net cash used in operating activities
-7,458 -24,263
Purchases of investments
34,508 63,523
Maturities of investments
40,000 77,600
Purchases of property and equipment
300 1,237
Acquisition of business, net of cash acquired of 541
0 1,773
Net cash provided by investing activities
5,192 11,067
Proceeds from exercise of stock options
14 403
Proceeds from issuance of common stock under employee stock purchase plan
0 134
Net cash provided by financing activities
14 537
Net decrease in cash and cash equivalents
-2,252 -12,659
Cash and cash equivalents at beginning of period
27,884 -
Cash and cash equivalents at end of period
12,973 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

MAXCYTE, INC. (MXCT)

MAXCYTE, INC. (MXCT)